Latest filing published 21 Aug 2024 for Nykode Therapeutics ASA, €24k.
Filing timeline
BuySaleMartin Nicklasson: trading record in brief
All filings by Martin Nicklasson on record concern Nykode Therapeutics ASA. We count 5 filings; the first trade dates from 22 February 2022 and the latest from 21 August 2024.
Purchases make up the whole of the open-market record (5 purchases, €172k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2024 to date brings 2 purchases and no sales.
The median purchase comes to €31k. 2 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The newest entry dates from 21 August 2024: an open-market purchase of €24k, in Nykode Therapeutics ASA. Every figure here comes from the filings published by Oslo Børs and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Martin Nicklasson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ NOK 5.6514.0% of flowShareXOSLOSLO:625848Canonical exit: 19 Nov 2024 (T+90)
- 40,000 shares@ NOK 13.8128.1% of flowShareXOSLOSLO:612998Canonical exit: 6 Jun 2024 (T+90)
- 20,000 shares@ NOK 16.3616.1% of flowShareXOSLOSLO:602442Canonical exit: 25 Jan 2024 (T+90)
- 10,000 shares@ NOK 32.0517.9% of flowShareMERKOSLO:562554Canonical exit: 16 Aug 2022 (T+90)
- 10,000 shares@ NOK 42.0023.9% of flowShareMERKOSLO:554554Canonical exit: 23 May 2022 (T+90)
5 of 5 declarations